Abstract
Zebrafish (Danio rerio) is now firmly recognized as a powerful research model for many areas of biology and medicine. Here, we review some achievements of zebrafish-based assays for modeling human diseases and for drug discovery and development. For drug discovery, zebrafish is especially valuable during the earlier stages of research as its represents a model organism to demonstrate a new treatment’s efficacy and toxicity before more costly mammalian models are used. This review considers some examples of known compounds which exhibit both physiological activity and toxicity in humans and zebrafish. The major advantages of zebrafish embryos consist in their permeability to small molecules added to their incubation medium and chorion transparency that enables the easy observation of the development. Assay of acute toxicity (LC50 estimation) in embryos can also include the screening for developmental disorders as an indicator of teratogenic effects. We have used the zebrafish model for toxicity testing of new drugs based on phospholipid nanoparticles (e.g. doxorubicin). Genome organization and the pathways involved into control of signal transduction appear to be highly conserved between zebrafish and humans and therefore zebrafish may be used for modeling of human diseases. The review provides some examples of zebrafish application in this field.
Similar content being viewed by others
References
Rubinstein, A.L., Expert Opin. Drug Metabol. Toxicol., 2006, vol. 2, pp. 231–240.
Kari, G., Rodeck, U., and Dicker, A.P., Clin. Pharmacol. Therapet., 2007, vol. 82, pp. 70–80.
Lieschke, G.J. and Currie, P.D., Nature Reviews Genetics, 2007, vol. 8, pp. 353–367.
Crawford, A.D., Esguerra, C.V., and de Witte, P.A.M., Planta Med., 2008, vol. 74, pp. 624–632.
Berghmans, S., Butler, P., Goldsmith, P., Waldron, G., Gardner, I., Golder, Z., Richards, F.M., Kimber, G., Roach, A., Alderton, W., and Fleming, A., J. Pharmacol. Toxicol. Methods, 2008, vol. 58, pp. 59–68.
McGrath, P. and Li, Chun-Q., Drug Discov. Today, 2008, vol. 13, pp. 394–401.
Langheinrich, U., Bioassays, 2003, vol. 25, pp. 904–912.
ISO 7346-1:1996.
OECD (1992) Test Guideline 203. OECD Guideline for Testing of Chemicals. Fish, Acute Toxicity Test.
Vosylien, Z., Acta Zoolog. Lituanica, 2007, vol. 17, pp. 3–15.
Braunbeck, T., Böttcher, M., Holler, H., Kosmeh, T., Lammer, E., Leist, E., Rudolf, M., and Seitz, N., ALTEX, 2005, vol. 22, pp. 87–102.
Nagel, R., ALTEX, 2002, vol. 19, pp. 38–48.
Braunbeck, T. and Lammer, E., Background Paper on Fish Embryo Toxicity Assays (UBA Contract Number 20385422) German Federal Environmental Agency, Dessau, 2006.
OECD, Guideline for Testing of Chemicals. Draft Proposal for a New Guideline. Fish Embryo Toxicity (FET) Test, 2006.
Scholz, S., Fischer, S., Gündel, U., Küster, E., Luckenbach, T., and Voelker, D., Environ. Sci. Pollut. Res., 2008, vol. 15, pp. 394–404.
Parng, C., Wen Lin, Seng, Semino, C., and McGrath, P., Assay and Drug Develop. Technol., 2002, vol. 1, pp. 1–8.
Tanguay, R.L., Neurotoxicol. Teratol., 2006, vol. 28, pp. 497–508.
Arenzana, F.J., Carvan, M.J., Aijón, J., Sánchez-González, R., Arévalo, R., and Porteros, A., Neurotoxicol. Teratol., 2006, vol. 28, pp. 342–348.
Carvan, M.J., Loucksa, E., Weberb, D.N., and Williams, F.E., Neurotoxicol. Teratol., 2004, vol. 26, pp. 757–768.
Seng, W.L., Toxicologist, 2007, vol. 96(Suppl.), p. 145.
Zon, L. and Peterson, R.T., Nature. Rev. Drug Discov., 2005, vol. 4, pp. 35–44.
Folkman, J., Nature Rev. Drug Discov., 2007, vol. 6, pp. 273–286.
Serbedzija, G. N., Angiogenesis, 1999, vol. 3, pp. 353–359.
Kidd, K.R. and Weinstein, B.M., British J. Pharmacol., 2003, vol. 140, pp. 585–594.
Cross, L.M., Cook, M.A., Lin, S., Chen, J.N., and Rubinstein, A.L., Arterioscler. Thromb. Vasc. Biol., 2003, vol. 23, pp. 911–912.
Langheinrich, U., Hennen, E., Stot, G., and Vacun, G., Curr. Biol., 2002, vol. 12, pp. 2023–2028.
Ton, C. and Parng, C., Hear. Res., 2005, vol. 208, pp. 79–88.
Zhang, C., Willett, C., and Fremgen, T., Curr. Protoc. Toxicol., 2003, pp. 1.7.1–1.7.18.
Chaoyong, M.A., Amer. Chem. Soc. Modern Drug Discovery, 2004, pp. 30–36.
Goldsmith, P., Curr. Opinion in Pharmacol., 2004, vol. 4, pp. 504–512.
Mlan, D.J., Peterson, T.A., Ruskin, J.N., Peterson, R.T., and MacRae, C.A., Circulation, 2003, vol. 107, pp. 1355–1358.
Boehmler, W., Carr, T., Thisse, C., Thisse, B., Canfield, V.A., and Levenson, R., Genes Brain Behav., 2007, vol. 6, pp. 155–166.
Airhart, M.J., Lee, D.H., Wilson, T.D., Miller, B.E., Miller, M.N., and Skalko, R.G., Neurotoxicol. Teratol., 2007, vol. 29, pp. 652–664.
Zhdanova, I.V., Wang, S.Y., Leclair, O.U., and Danilova, N.P., Brain Res., 2001, vol. 903, pp. 263–268.
Lockwood, B., Bjerke, S., Kobayashi, K., and Guo, S., Pharmacol. Biochem. Behav., 2004, vol. 77, pp. 647–654.
Barros, T.P., Alderton W.K., Reynolds, H.M., Roach, A.G., and Berghmans, S., British J. Pharmacol., 2008, vol. 154, pp. 1400–1413.
Heiden, T.C, Dengler, E., Kao, W.J., Heideman, W., and Peterson, R.E., Toxicol. Appl. Pharmacol., 2007, vol. 225, pp. 70–79.
Lee, K.J., Nallathamby, P.D., Browning, L.M., Osgood, C.J., and Xu, X.N., ACSNANO, 2007, vol. 1, pp. 133–144.
Gundel, U., Benndorf, D., von Bergen, M., Altenburger, R., and Kuster, E., Proteomics, 2007, vol. 7, pp. 4541–4554.
Tseng, H.P., Hseu, T.H., Buhler, D.R., Wang, W.D., and Hu, C.H., Toxicol. Appl. Pharmacol., 2005, vol. 205, pp. 247–258.
Li, C.Q., Toxicologist, 2008, vol. 97(Suppl.), p. 148.
Dean, M. and Annilo, T., Annu. Rev. Genomics Hum. Genet., 2005, vol. 6, pp. 123–142.
Lam, C.S., Korz, H.V., and Strahl, E.U., Eur. J. Neurosci., 2005, vol. 21, pp. 1758–1762.
Gerhard, G.S., Experimen. Gerontol., 2003, vol. 38, pp. 1333–1341.
Elo, B., Villano, C.M., Govorco, D., and White, L.A., J. Mol. Endocinol., 2007, vol. 38, pp. 433–440.
Pyati, U.J., Look, A.T., and Hammerschmidt, M., Semin. Cancer Biol., 2007, vol. 17, pp. 154–165.
Silva, M.T., Vale, A., and dos Santos, N.M.S., Curr. Pharmac. Design, 2008, vol. 14, pp. 170–183.
Meng, X.W., Lee, S.H., and Kaufmann, S.H., Curr. Opin. Cell Biol., 2006, vol. 18, pp. 668–676.
dos Santos, N.M.S., do Vale, A., Reis, M.I.R., and Silva, M.T., Curr. Pharmaceut. Design, 2008, vol. 14, pp. 148–169.
Rubinstein, A.L., Curr. Opinion in Drug Discov. Develop., 2003, vol. 6, pp. 218–223.
Spitsbergen, J.M. and Kent, M.L., Toxicol. Pathol., 2003, vol. 31(Suppl), pp. 62–87.
Mizgireuv, I.V. and Revskoy, S.Y., Cancer Res., 2006, vol. 66, pp. 3120–3125.
Patton, E.E., Widlund, H.R., Kutok, J.L., Kopani, K.R., Amatruda, J.F., Murphey, R.D., Berghmans, S., Mayhall, E.A., Traver, D., Fletcher, C.D., Aster, J.C., Granter, S.R., Look, A.T., Lee, C., Fisher, D.E., and Zon, L.I., Curr. Biol., 2005, vol. 15, pp. 249–254.
Meeker, N.D. and Trede, N.S., Develop. Compar. Immunol., 2008, vol. 32, pp. 745–757.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.F. Belyaeva, V.N. Kashirtseva, N.V. Medvedeva, Yu.Yu. Khudoklinova, O.M. Ipatova, A. I. Archakov, 2009, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Belyaeva, N.F., Kashirtseva, V.N., Medvedeva, N.V. et al. Zebrafish as a model system for biomedical studies. Biochem. Moscow Suppl. Ser. B 3, 343–350 (2009). https://doi.org/10.1134/S1990750809040039
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750809040039